Experts sound the alarm over cancer-causing chemicals hidden in popular BEERS
A new study has detected a toxic group of cancer-causing chemicals known as PFAS in 'popular' beers brewed in North America and Europe.
The experts didn't reveal the name of the beers, although MailOnline has contacted them for a full list.
Worryingly, beer fans could be drinking down PFAS whether the beverage is fresh from the tap, a glass bottle or a can.
PFAS – or per-and polyfluoroalkyl substances – have been dubbed 'forever chemicals' because they are designed not to break down in the environment.
Studies have linked PFAS to infertility, behavioural problems, birth defects, high cholesterol levels and even various cancers, including kidney, testicular and ovarian.
'Nearly every American has PFAS in their blood,' say the researchers from RTI International research institute in North Carolina.
'We set out to understand whether popular craft beers as well as national and international beers may also be a contributor to total PFAS exposure for beer drinkers.'
The team believe PFAS chemicals are entering the beer from local contaminated water supplies used during the brewing process.
Water is the most abundant and important ingredient of the four main ingredients in beer (the others being hops, yeast and grain).
Although breweries typically have water filtration and treatment systems, they are not designed to remove PFAS, the team warn.
But extra PFAS sources could include brewing ingredients (such as grains, hops and spices), packaging or storing materials (storage tanks and cans), and cleaning supplies.
For example, packaging vessels such as bottles, cans, and kegs may also be washed with water or contain liners that could also introduce PFAS.
For the study, the researchers tested 23 lagers and ales – mostly from from the US, but also two from Mexico and one from the Netherlands.
The US beer came from eight states – North Carolina, Michigan, Colorado, California, Massachusetts, Pennsylvania, Wisconsin and Missouri.
Their selection comprised 'primarily plain lagers and ales' produced by US brewers in areas with documented water system contamination, plus popular domestic and international beers from larger companies with unknown water sources.
What are PFAS?
PFAS are human-made chemicals produced for their anti-grease, water-resistant, and stain-repelling properties.
PFAS have been widely used in consumer products (such as carpets, furniture, clothes, cookware, and food packaging), industrial manufacturing (e.g., as a processing aid in plastic production), and in firefighting foam for decades.
Often referred to as 'forever chemicals', they are ubiquitous in the environment due to their extensive use and resistance to degradation.
Recent studies show that PFAS exposure can lead to adverse reproductive, developmental, cardiovascular, liver, kidney, immunological, and carcinogenic health effects. Additionally, PFAS can remain in the body for years.
Source: Redmon et al 2025
Overall, the researchers found PFAS in 95 per cent of the beers they tested, including perfluorooctanesulfonate (PFOS) and perfluorooctanoic acid (PFOA).
Shockingly, these two types of PFAS were found in quantities above recently established limits in drinking water set by the Environmental Protection Agency (EPA).
Beers from smaller breweries had a higher likelihood of PFAS presence compared to larger-scale US or international beers.
The largest number of PFAS compounds were detected in beer from Chatham County and Mecklenburg County in North Carolina (both areas with PFAS in municipal drinking water), and a beer from St. Louis County, Missouri.
Beers from North Carolina exhibited higher PFAS 'species variety' – meaning a wider variety of different types of PFAS – compared to Michigan and California.
Unsurprisingly, parts of the country with known PFAS-contaminated water sources showed the highest levels of the 'forever chemicals'.
The results, published in the journal Environmental Science & Technology, suggest there's an urgent need for water treatment upgrades at brewing facilities.
Researchers also call for greater awareness among brewers, consumers and regulators to limit overall PFAS exposure, as well as more research into PFAS in beers brewed further around the world, including brewing giants such as China, Japan, Brazil, Germany and the UK.
Beer fans, meanwhile, should choose beers from breweries without PFAS in municipal drinking water, or that conduct testing and use water filtration that removes PFAS.
'Water utilities can enhance water treatment processes to remove PFAS contaminants before distribution, and breweries can test or filter their brewing water,' the team add.
PFAS were first developed in the 1940s and are widely used in industry as well as in consumer products such as non-stick cookware, water and stain-repellent coatings, food packaging, carpeting, firefighting foam and cosmetics.
Their molecular structure is based on a linked chain of carbon atoms with one or more fluorine atoms attached, and the extreme stability of those carbon-fluorine bonds make PFAS highly resistant to being broken down.
This durability causes PFAS to persist and accumulate in the environment as well as in the bodies of humans and animals for years.
Many PFAS have molecular structures that resemble those of naturally occurring fatty acids, resulting in them having similar chemical properties and effects on the human body.
Exposure to a type of man-made chemicals may cause menopause to occur two years earlier in women, a study warns.
Researchers from the University of Michigan found that high levels of PFAS in blood samples contributed to an earlier menopause in women.
PFAS, which are used as oil and water repellents and coatings for consumer products, can enter water sources and disrupt ovarian function, they say.
The chemicals, which are widely used in food packaging, cookware and industrial foams, disrupt the endocrine system – the hormone-producing collection of glands that regulate sexual function.
Previous studies have also linked them to infertility, behavioural problems, birth defects, high cholesterol levels and even cancer.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
14 minutes ago
- The Independent
This fuzzy animal friend may be the key to treating schizophrenia
Llamas – likely without red pajamas – may hold the key to treating schizophrenia. The serious brain disorder causes people to interpret reality abnormally, and affects approximately 3.7 million U.S. adults between the ages of 18 to 65 years old, according to the nonprofit RTI International. But the domesticated South American woolly animal might be be able to help. French researchers said this week that they had used llama antibodies, or proteins that help to protect the immune system, to design a tiny fragment of an antibody known as a 'nanobody' that will trigger a neurotransmitter in the brain involved in regulating neural activity. Neurotransmitters are chemical molecules that carry messages or signals from one nerve cell to the next target cell, according to the Cleveland Clinic. No llamas were harmed in the study and researchers can identify nanobodies in a petri dish. In the past, llama antibodies have also proven effective in fighting Covid and other 'SARS-like' viruses. When scientists at the Institute of Functional Genomics injected the molecule into the veins or the muscles, it was able to break the blood-brain barrier and effectively reach brain receptors. The barrier is a a tightly locked layer of cells that defend your brain from harmful substances. Studying the impact of the nanobodies in two tests using mice, the researchers found that they corrected cognitive deficits that were observed. There was an improvement of cognitive function with just one shot, and a prolonged effect over one week. Clinical studies are now required to show that their findings could be a new avenue of treatment for schizophrenia. "In humans obviously we don't know [yet], but in mice yes, it is sufficient to treat most deficits of schizophrenia," molecular biologist Jean-Philippe Pin told Newsweek.. He was a co-author of the research which was published in the journal Nature. Pin said that medications currently given to schizophrenia patients "treat the symptoms well, but less the cognitive deficits." The cause of the chronic condition remains unknown, but the World Health Organization says it is thought that an interaction between genes and a range of environmental factors may be the reason. The exact prevalence of schizophrenia is difficult to measure. Some have tied cases in Canada to cannabis use. Although schizophrenia can occur at any age, people are typically diagnosed between the ages of 16 and 30. Symptoms vary from person to person. There is no cure, but it can be treated through antipsychotic medications, talk therapy, and self-management strategies, the National Alliance on Mental Illness says. The study's authors hope to add this strategy to the list. 'This research confirms the potential of nanobodies as a new therapeutic strategy for acting on the brain, with their use eventually being broadened to include the treatment of other neurological illnesses,' the institute said in a statement.
The Independent
an hour ago
- The Independent
Millions of people are suffering from brain fog. A new study will find out why
Millions of people who recover from infections like COVID-19, influenza and glandular fever are affected by long-lasting symptoms. These include chronic fatigue, brain fog, exercise intolerance, dizziness, muscle or joint pain and gut problems. And many of these symptoms worsen after exercise, a phenomenon known as post-exertional malaise. Medically the symptoms are known as myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS). The World Health Organization classifies this as a post viral fatigue syndrome, and it is recognised by both the WHO and the United States Centers for Disease Control and Prevention as a brain disorder. Experiencing illness long after contracting an infection is not new, as patients have reported these symptoms for decades. But COVID-19 has amplified the problem worldwide. Nearly half of people with ongoing post-COVID symptoms – a condition known as long-COVID – now meet the criteria for ME/CFS. Since the start of the pandemic in 2020, it is estimated that more than 400 million people have developed long-COVID. To date, no widely accepted and testable mechanism has fully explained the biological processes underlying long-COVID and ME/CFS. Our work offers a new perspective that may help close this gap. Our research group studies blood and the cardiovascular system in inflammatory diseases, as well as post-viral conditions. We focus on coagulation, inflammation and endothelial cells. Endothelial cells make up the inner layer of blood vessels and serve many important functions, like regulating blood clotting, blood vessel dilation and constriction, and inflammation. Our latest review aims to explain how ME/CFS and long-COVID start and progress, and how symptoms show up in the body and its systems. By pinpointing and explaining the underlying disease mechanisms, we can pave the way for better clinical tools to diagnose and treat people living with ME/CFS and long-COVID. What is endothelial senescence? In our review, our international team proposes that certain viruses drive endothelial cells into a half-alive, 'zombie-like' state called cellular senescence. Senescent endothelial cells stop dividing, but continue to release molecules that awaken and confuse the immune system. This prompts the blood to form clots and, at the same time, prevent clot breakdown, which could lead to the constriction of blood vessels and limited blood flow. By placing 'zombie' blood-vessel cells at the centre of these post-viral diseases, our hypothesis weaves together microclots, oxygen debt (the extra oxygen your body needs after strenuous exercise to restore balance), brain-fog, dizziness, gut leakiness (a digestive condition where the intestinal lining allows toxins into the bloodstream) and immune dysfunction into a single, testable narrative. From acute viral infection to 'zombie' vessels Viruses like SARS-CoV-2, Epstein–Barr virus, HHV-6, influenza A, and enteroviruses (a group of viruses that cause a number of infectious illnesses which are usually mild) can all infect endothelial cells. They enable a direct attack on the cells that line the inside of blood vessels. Some of these viruses have been shown to trigger endothelial senescence. Multiple studies show that SARS-CoV-2 (the virus which causes COVID-19 disease) has the ability to induce senescence in a variety of cell types, including endothelial cells. Viral proteins from SARS-CoV-2, for example, sabotage DNA-repair pathways and push the host cell towards a senescent state, while senescent cells in turn become even more susceptible to viral entry. This reciprocity helps explain why different pathogens can result in the same chronic illness. Influenza A, too, has shown the ability to drive endothelial cells into a senescent, zombie-like state. What we think is happening We propose that when blood-vessel cells turn into 'zombies', they pump out substances that make blood thicker and prone to forming tiny clots. These clots slow down circulation, so less oxygen reaches muscles and organs. This is one reason people feel drained. During exercise, the problem worsens. Instead of the vessels relaxing to allow adequate bloodflow, they tighten further. This means that muscles are starved of oxygen and patients experience a crash the day after exercise. In the brain, the same faulty cells let blood flow drop and leak, bringing on brain fog and dizziness. In the gut, they weaken the lining, allowing bits of bacteria to slip into the bloodstream and trigger more inflammation. Because blood vessels reach every corner of the body, even scattered patches of these 'zombie' cells found in the blood vessels can create the mix of symptoms seen in long-COVID and ME/CFS. Immune exhaustion locks in the damage Some parts of the immune system kill senescent cells. They are natural-killer cells, macrophages and complement proteins, which are immune molecules capable of tagging and killing pathogens. But long-COVID and ME/CFS frequently have impaired natural-killer cell function, sluggish macrophages and complement dysfunction. Senescent endothelial cells may also send out a chemical signal to repel immune attack. So the 'zombie cells' actively evade the immune system. This creates a self-sustaining loop of vascular and immune dysfunction, where senescent endothelial cells persist. In a healthy person with an optimally functioning immune system, these senescent endothelial cells will normally be cleared. But there is significant immune dysfunction in ME/CFS and long-COVID, and this may enable the 'zombie cells' to survive and the disease to progress. Where the research goes next There is a registered clinical trial in the US that is investigating senescence in long-COVID. Our consortium is testing new ways to spot signs of ageing in the cells that line our blood vessels. First, we expose healthy endothelial cells in the lab to blood from patients to see whether it pushes the cells into a senescent, or 'zombie,' state. At the same time, we are trialling non‑invasive imaging and fluorescent probes that could one day reveal these ageing cells inside the body. In selected cases, tissue biopsies may later confirm what the scans show. Together, these approaches aim to pinpoint how substances circulating in the blood drive cellular ageing and how that, in turn, fuels disease. Our aim is simple: find these ageing endothelial cells in real patients. Pinpointing them will inform the next round of clinical trials and open the door to therapies that target senescent cells directly, offering a route to healthier blood vessels and, ultimately, lighter disease loads.
Daily Mail
2 hours ago
- Daily Mail
Doctors dismissed my symptoms as a sinus infection... a year later I found out I had a deadly brain tumor
Long before becoming a patient, Ilene Sue Ruhoy was a prominent neurologist in Seattle, accustomed to treating disease. She had been practicing for a decade when, in 2014, she noticed mounting fatigue, dizziness, nausea, migraines, and irritability that various doctors chalked up to stress, a hormone imbalance, and a sinus infection. None of them, she felt, truly listened or took her symptoms seriously. In August 2015, after a year of asking doctors to order her an MRI, one of them finally listened, and what appeared on the scan changed the course of her life entirely. At the emergency room, doctors informed her that she had a tumor called a meningioma the size of an apple pressing on the left side of her brain so forcefully that both hemispheres were being pushed to the right side of her skull. While not classified as cancer, meningiomas can be deadly if complications arise, boasting a mortality rate of anywhere from 63 to 90 percent. She underwent multiple surgeries to seal off the blood vessel feeding the tumor in the hopes of preventing it from growing larger, followed by a procedure to remove the mass in its entirety. 'It's only when I look back in time and think through those appointments and the conversations, and I was at the point where I was begging people to believe me,' Ruhoy told 'The sad part is that if someone had believed me earlier on, I think I could have prevented a lot of the recurrences that I had to go through because I've now undergone three rounds of radiation to my brain.' Ruhoy was healthy before her medical crisis, like many of her current patients. She questioned how this could have happened, feeling she had done everything right. During her quest for answers, Ruhoy complained of light sensitivity and severe, long-lasting migraines that doctors told her were due to her stressful job as a neurologist in a hospital. She said one doctor stayed glued to their computer and failed to even make eye contact with her. Another told her, after she begged for an MRI because she knew something was wrong, that he 'didn't want to feed into the hysteria by ordering an MRI.' She said 'Looking back, I think that I just wasn't cognizant of what was really happening when it was happening. 'And it's only when I look back in time and think through those appointments and basically I was at the point where I was like begging people to believe me, because things just were getting worse for me.' Around nine months into her illness, before being diagnosed, she found a primary care doctor and as soon as Ruhoy walked into her new doctor's office, she began to sob, telling the physician that she had reached her wit's end. 'All I said was, please, just order me an MRI. And she said the famous words, "when a neurologist asks you to order a brain MRI, you order a brain MRI,"' Ruhoy said. 'I remember that moment when she just agreed and I almost hugged her. I didn't, I should have, but I was just so grateful, and I will always be grateful.' Ruhoy still does not know definitively what caused her own tumor. She said: 'I have a PhD in environmental toxicology, so I've thought long and hard about this; what exposures have I had in my life, what infections have I had in my life. 'Once I was diagnosed, I underwent a big workup, led by myself, to try to answer that exact question, and I really came up with nothing. We don't really know what causes these tumors.' Inspired by her own journey, Ruhoy would come to specialize in complex post-exposure illnesses (PEIs), such as long Covid and chronic fatigue syndrome. People with poorly understood chronic illnesses fed by exposure to certain medications, pathogens, or trauma generally describe feeling 'gaslit' by their doctors who don't adequately listen to their concerns, often brush them off as being due to stress, give up trying to treat patients, and alienate them. She vowed to help patients who have felt let down by the medical establishment and to not allow them to leave her office without setting forth on the path to recovery. PEIs encompass several diagnoses marked by a wide array of symptoms. According to Ruhoy, exposure can be to anything external and does not always involve an infection. For instance, she said, long-term exposure to pesticides or mold have been linked to cases of Parkinson's, multiple sclerosis, and chronic fatigue syndrome. Her newfound career treating PEIs began with Danielle, a dancer in her early 30s who developed debilitating joint pain, food allergies, hives, swelling in her hands and feet, dizziness, headaches, and neck pain. Many of her patients today are on their fourth or fifth healthcare professional in their quest to figure out what is driving their symptoms. Danielle was no different. She asked Danielle a laundry list of questions, questions no doctor had asked her before: Did she ever have any pain disorders? Did family members have similar symptoms to hers? Did she choke a lot? Did she have chest pain? A detailed blood test revealed Danielle's hypothyroidism, missed by other doctors who hadn't ordered a comprehensive panel. This likely caused her fatigue, menstrual issues, hair loss, bloating, and skin changes. Dr Ruhoy addressed each symptom: an MRI uncovered a misdiagnosed spinal problem, treated with muscle relaxants; medication stabilized her dizziness; and specialists managed her heart and joint pain. Within months, Danielle felt significantly better. In addition to treating patients' symptoms with medication, Ruhoy recommends drug-free treatments: being active, even for a short walk, time in nature, and following a consistent sleep schedule. 'Will you ever be 'normal' again? It's a question I hear often from patients, and unfortunately— if by 'normal' you mean a full return to the person you were before this chronic illness... I can't promise that you will,' Ruhoy wrote in her book Invisible No More. 'However, if you care for yourself, if you remain diligent in the ways we have discussed, and if you attend to your body and listen to the signals it sends you… then you have a great chance of being well. Very well, even.'
